Life insurance with hepatitis C

Hepatitis C does not make life insurance impossible, and since modern treatment can cure the infection, many applicants now have a history of hepatitis C rather than an active infection. Underwriters generally focus on whether the virus has been cleared, how much liver damage occurred, how long ago treatment ended, and any related alcohol or drug use. A cured infection with a healthy liver can be rated far better than active infection or cirrhosis, though how insurers treat each case varies.

What hepatitis C is, and what changed

According to the Centers for Disease Control and Prevention, treatment cures more than 95% of people with hepatitis C, usually without side effects, and most regimens are 8 to 12 weeks of oral medication. Left untreated, chronic hepatitis C can lead to liver scarring, cirrhosis, liver cancer and liver failure. CDC estimated that between 2017 and 2020 about 2.4 to 4 million people in the U.S. had hepatitis C, and notes that many people have no symptoms for years, which is why it recommends testing for all adults.

Because a person can carry the virus for decades before being diagnosed, an insurer may learn about it for the first time through your application blood work. That is one reason the details of your testing history matter.

What underwriters typically consider

Insurer practices differ, but these are the usual questions:

• Cured or active? A "sustained virologic response" (SVR), meaning the virus is undetectable in blood tests about 12 weeks after treatment ends, is considered a cure. Active, untreated infection is viewed as higher risk.
• Time since treatment. A longer period since cure with stable results generally helps.
• Liver damage (fibrosis or cirrhosis). Doctors stage fibrosis from none or mild to cirrhosis, using biopsy, imaging such as elastography, or blood-based scores. Little or no scarring is far more favorable than advanced fibrosis or cirrhosis. Cirrhosis makes standard coverage difficult to obtain even after viral cure.
• Liver tests. Your ALT and AST liver enzymes and other results on the what a life insurance blood and urine test looks for are read closely.
• Alcohol and drug use. How the infection was acquired and current or past substance use matter; see life insurance in recovery from substance use.
• Coinfection. HIV or hepatitis B alongside hepatitis C raises complexity (see Life insurance with HIV).
• Liver cancer screening and complications. Any history of liver cancer, varices or fluid buildup is a major factor.
• Age and other health. As always, age, tobacco use, weight and other conditions affect the final class.

Depending on the facts, an insurer might offer a standard or better class, a table rating or flat extra, postpone the decision, or decline. See life insurance rate classes: preferred plus to substandard and table ratings and flat extras explained for how ratings work.

Active infection

If you have been diagnosed but not yet treated, many insurers will postpone an application until treatment is completed and cure is documented, since treatment is short and effective. A postponement is not a permanent decline; see postponed application: why insurers make you wait. Waiting to apply until you have your SVR result can lead to a better outcome than applying mid-treatment, but you should not go without coverage you need longer than necessary. If you have no existing policy and a family relies on your income, ask an agent whether a different policy type is an option in the meantime.

What to expect in the application

1. Application questions. You will be asked whether you have ever been diagnosed with or treated for hepatitis, when, and with what medication.
2. Exam and labs. A paramedical exam usually includes blood and urine tests, with liver enzymes and often a hepatitis screening.
3. Records. The insurer may request an attending physician statement with your viral load history, treatment dates, SVR result, and any imaging or biopsy results.
4. Prescription check. Hepatitis C medicines show in prescription histories (see how insurers check your prescription history).

How to prepare

• Ask your doctor for a short letter stating the diagnosis date, the treatment you took and when it ended, your SVR result and the most recent fibrosis assessment.
• Gather your latest liver panel and imaging.
• Report your history accurately. Leaving out a past infection can allow the insurer to contest a claim within the the two-year contestability period.
• Ask an independent agent which carriers are currently receptive to cured hepatitis C, because appetite varies.
• If you are declined, see Declined for life insurance? What to do next for next steps, including group coverage and guaranteed issue life insurance: no health questions, with limits.

After cure: ongoing follow-up

A cure clears the virus, but it does not reverse every effect. People who had significant scarring before treatment may still need periodic liver monitoring, including imaging to screen for liver cancer, and underwriters often ask whether that follow-up is happening and what it has shown. If your fibrosis was mild or absent, your doctor may recommend little follow-up, which is itself a favorable detail to document. Staying away from heavy alcohol use is also commonly advised, and insurers may ask about it directly. Keeping your own copies of lab results over the years makes later applications and any rate reconsideration easier (see asking for a better rate class later).

A hypothetical example

Say a 44-year-old was diagnosed with hepatitis C 5 years ago, completed a 12-week treatment, had an undetectable virus at the follow-up test, has mild or no scarring, normal liver enzymes and no heavy alcohol use. Some insurers may consider that a favorable file, possibly at or near standard. Say another applicant of the same age has advanced fibrosis and an unclear treatment history. That file would likely be rated significantly or declined. These are illustrations, not predictions.

Key takeaways

• Hepatitis C is curable in more than 95% of treated patients, according to the CDC, and a cure can substantially improve your insurability.
• Underwriters focus on cure (SVR), time since treatment, liver scarring, liver enzymes and alcohol or drug history.
• Cirrhosis and active untreated infection are the hardest profiles to insure; expect a postponement or high rating.
• Bring a doctor's letter and lab results, answer fully, and compare more than one insurer.